BioMarin Pharmaceutical, Inc. (BMRN)
53.68
-0.06
(-0.11%)
USD |
NASDAQ |
Dec 10, 16:00
53.68
0.00 (0.00%)
After-Hours: 18:11
BioMarin Pharmaceutical Total Assets (Quarterly): 7.615B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Align Technology, Inc. | 6.234B |
| Biogen, Inc. | 29.21B |
| Gilead Sciences, Inc. | 58.53B |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Moderna, Inc. | 12.14B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.558B |
| Shareholders Equity (Quarterly) | 6.057B |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 4.828 |
| Net Debt Paydown Yield | 0.94% |